Nuclear Medicine Market Size, Share, and Outlook, H2-2025 Report- By Product (SPECT Diagnostic Products, PET Diagnostic Products, Therapeutic Products, Alpha Emitters, Beta Emitters, Brachytherapy), By Application (Cardiology, Neurology, Oncology, Thyroid
Description
Nuclear Medicine Market Outlook
The global Nuclear Medicine Market Size is valued at $16.8 Billion in 2025 and is forecast to reach $34.4 Billion in 2032 at a CAGR of 10.8%.
The Nuclear Medicine Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Nuclear Medicine Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (SPECT Diagnostic Products, PET Diagnostic Products, Therapeutic Products, Alpha Emitters, Beta Emitters, Brachytherapy), By Application (Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Nuclear Medicine Market Insights, 2025
The Nuclear Medicine Market has witnessed strong momentum due to breakthroughs in targeted radiopharmaceuticals and theranostics. The approval of novel PET tracers for cancer and neurological disorders, such as prostate-specific membrane antigen (PSMA)-targeted agents, has expanded clinical applications. Radiotheranostics—combining diagnostic imaging and targeted radiotherapy—are gaining traction, with new pipeline candidates showing promise in oncology. Technological advancements in cyclotron production and generator-based isotope supply are improving accessibility to short-lived isotopes. Additionally, regulatory support for personalized medicine is driving the integration of nuclear medicine into precision oncology workflows. The market is also seeing significant investment in hybrid imaging modalities like PET/MRI for improved diagnostic accuracy.
Five Trends Shaping the Global Nuclear Medicine Market in 2025 and Beyond
The global Nuclear Medicine Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Nuclear Medicine Industry?
The Nuclear Medicine Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Nuclear Medicine Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Nuclear Medicine Market Segment Insights
The Nuclear Medicine Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (SPECT Diagnostic Products, PET Diagnostic Products, Therapeutic Products, Alpha Emitters, Beta Emitters, Brachytherapy), By Application (Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Nuclear Medicine Industry Value Chain
The chapter identifies potential companies and their operations across the global Nuclear Medicine Industry ecosystem. It assists decision-makers in evaluating global Nuclear Medicine Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Nuclear Medicine Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Nuclear Medicine Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Nuclear Medicine Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Nuclear Medicine Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Nuclear Medicine Market.
Europe Nuclear Medicine Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Nuclear Medicine Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Nuclear Medicine Industry competitiveness. The report analyses the key Nuclear Medicine Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Nuclear Medicine Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Nuclear Medicine Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Nuclear Medicine Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Nuclear Medicine Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Nuclear Medicine Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Nuclear Medicine Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Bayer AG, Bracco Imaging S.p.A., Cardinal Health Inc, Curium Pharma, Eckert & Ziegler Group, Eczacibasi-Monrol Nuclear Products, GE Healthcare, Isotope JSC, Jubilant DraxImage Inc, Lantheus Holdings Inc, Nordion Inc, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, PharmaLogic Holdings Corp, Siemens Healthineers AG. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Nuclear Medicine Market Scope
Leading Segments
By Product
SPECT Diagnostic ProductsTC-99m TL-201 GA-67 I-123 Others
PET Diagnostic ProductsF-18 SR-82/RB-82 Others
Therapeutic Products
Alpha Emitters
Beta Emitters
Brachytherapy
By Application
Cardiology
Neurology
Oncology
Thyroid
Lymphoma
Bone Metastasis
Endocrine Tumor
Others
By End-User
Hospitals & Clinics
Diagnostic Centers
Others
Leading Companies
Bayer AG
Bracco Imaging S.p.A.
Cardinal Health Inc
Curium Pharma
Eckert & Ziegler Group
Eczacibasi-Monrol Nuclear Products
GE Healthcare
Isotope JSC
Jubilant DraxImage Inc
Lantheus Holdings Inc
Nordion Inc
NorthStar Medical Radioisotopes LLC
NTP Radioisotopes SOC Ltd
PharmaLogic Holdings Corp
Siemens Healthineers AG
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Nuclear Medicine Market Size is valued at $16.8 Billion in 2025 and is forecast to reach $34.4 Billion in 2032 at a CAGR of 10.8%.
The Nuclear Medicine Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Nuclear Medicine Market segments across 22 countries from 2021 to 2032. Key segments covered include By Product (SPECT Diagnostic Products, PET Diagnostic Products, Therapeutic Products, Alpha Emitters, Beta Emitters, Brachytherapy), By Application (Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Nuclear Medicine Market Insights, 2025
The Nuclear Medicine Market has witnessed strong momentum due to breakthroughs in targeted radiopharmaceuticals and theranostics. The approval of novel PET tracers for cancer and neurological disorders, such as prostate-specific membrane antigen (PSMA)-targeted agents, has expanded clinical applications. Radiotheranostics—combining diagnostic imaging and targeted radiotherapy—are gaining traction, with new pipeline candidates showing promise in oncology. Technological advancements in cyclotron production and generator-based isotope supply are improving accessibility to short-lived isotopes. Additionally, regulatory support for personalized medicine is driving the integration of nuclear medicine into precision oncology workflows. The market is also seeing significant investment in hybrid imaging modalities like PET/MRI for improved diagnostic accuracy.
Five Trends Shaping the Global Nuclear Medicine Market in 2025 and Beyond
The global Nuclear Medicine Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Nuclear Medicine Industry?
The Nuclear Medicine Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Nuclear Medicine Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Nuclear Medicine Market Segment Insights
The Nuclear Medicine Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Product (SPECT Diagnostic Products, PET Diagnostic Products, Therapeutic Products, Alpha Emitters, Beta Emitters, Brachytherapy), By Application (Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Nuclear Medicine Industry Value Chain
The chapter identifies potential companies and their operations across the global Nuclear Medicine Industry ecosystem. It assists decision-makers in evaluating global Nuclear Medicine Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Nuclear Medicine Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Nuclear Medicine Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Nuclear Medicine Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Nuclear Medicine Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Nuclear Medicine Market.
Europe Nuclear Medicine Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Nuclear Medicine Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Nuclear Medicine Industry competitiveness. The report analyses the key Nuclear Medicine Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Nuclear Medicine Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Nuclear Medicine Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Nuclear Medicine Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Nuclear Medicine Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Nuclear Medicine Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Nuclear Medicine Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Bayer AG, Bracco Imaging S.p.A., Cardinal Health Inc, Curium Pharma, Eckert & Ziegler Group, Eczacibasi-Monrol Nuclear Products, GE Healthcare, Isotope JSC, Jubilant DraxImage Inc, Lantheus Holdings Inc, Nordion Inc, NorthStar Medical Radioisotopes LLC, NTP Radioisotopes SOC Ltd, PharmaLogic Holdings Corp, Siemens Healthineers AG. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Nuclear Medicine Market Scope
Leading Segments
By Product
SPECT Diagnostic Products
PET Diagnostic Products
Therapeutic Products
Alpha Emitters
Beta Emitters
Brachytherapy
By Application
Cardiology
Neurology
Oncology
Thyroid
Lymphoma
Bone Metastasis
Endocrine Tumor
Others
By End-User
Hospitals & Clinics
Diagnostic Centers
Others
Leading Companies
Bayer AG
Bracco Imaging S.p.A.
Cardinal Health Inc
Curium Pharma
Eckert & Ziegler Group
Eczacibasi-Monrol Nuclear Products
GE Healthcare
Isotope JSC
Jubilant DraxImage Inc
Lantheus Holdings Inc
Nordion Inc
NorthStar Medical Radioisotopes LLC
NTP Radioisotopes SOC Ltd
PharmaLogic Holdings Corp
Siemens Healthineers AG
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
182 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Nuclear Medicine Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Nuclear Medicine Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Nuclear Medicine Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Nuclear Medicine Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Nuclear Medicine Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Product
- SPECT Diagnostic Products
- -TC-99m
- -TL-201
- -GA-67
- -I-123
- -Others
- PET Diagnostic Products
- -F-18
- -SR-82/RB-82
- -Others
- Therapeutic Products
- Alpha Emitters
- Beta Emitters
- Brachytherapy
- By Application
- Cardiology
- Neurology
- Oncology
- Thyroid
- Lymphoma
- Bone Metastasis
- Endocrine Tumor
- Others
- By End-User
- Hospitals & Clinics
- Diagnostic Centers
- Others
- 6. Global Nuclear Medicine Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Nuclear Medicine Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Nuclear Medicine Market Trends and Growth Opportunities
- 6.2.1 North America Nuclear Medicine Market Outlook by Type
- 6.2.2 North America Nuclear Medicine Market Outlook by Application
- 6.3 North America Nuclear Medicine Market Outlook by Country
- 6.3.1 The US Nuclear Medicine Market Outlook, 2021- 2032
- 6.3.2 Canada Nuclear Medicine Market Outlook, 2021- 2032
- 6.3.3 Mexico Nuclear Medicine Market Outlook, 2021- 2032
- 7. Europe Nuclear Medicine Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Nuclear Medicine Market Trends and Growth Opportunities
- 7.2.1 Europe Nuclear Medicine Market Outlook by Type
- 7.2.2 Europe Nuclear Medicine Market Outlook by Application
- 7.3 Europe Nuclear Medicine Market Outlook by Country
- 7.3.2 Germany Nuclear Medicine Market Outlook, 2021- 2032
- 7.3.3 France Nuclear Medicine Market Outlook, 2021- 2032
- 7.3.4 The UK Nuclear Medicine Market Outlook, 2021- 2032
- 7.3.5 Spain Nuclear Medicine Market Outlook, 2021- 2032
- 7.3.6 Italy Nuclear Medicine Market Outlook, 2021- 2032
- 7.3.7 Russia Nuclear Medicine Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Nuclear Medicine Market Outlook, 2021- 2032
- 8. Asia Pacific Nuclear Medicine Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Nuclear Medicine Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Nuclear Medicine Market Outlook by Type
- 8.2.2 Asia Pacific Nuclear Medicine Market Outlook by Application
- 8.3 Asia Pacific Nuclear Medicine Market Outlook by Country
- 8.3.1 China Nuclear Medicine Market Outlook, 2021- 2032
- 8.3.2 India Nuclear Medicine Market Outlook, 2021- 2032
- 8.3.3 Japan Nuclear Medicine Market Outlook, 2021- 2032
- 8.3.4 South Korea Nuclear Medicine Market Outlook, 2021- 2032
- 8.3.5 Australia Nuclear Medicine Market Outlook, 2021- 2032
- 8.3.6 South East Asia Nuclear Medicine Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Nuclear Medicine Market Outlook, 2021- 2032
- 9. South America Nuclear Medicine Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Nuclear Medicine Market Trends and Growth Opportunities
- 9.2.1 South America Nuclear Medicine Market Outlook by Type
- 9.2.2 South America Nuclear Medicine Market Outlook by Application
- 9.3 South America Nuclear Medicine Market Outlook by Country
- 9.3.1 Brazil Nuclear Medicine Market Outlook, 2021- 2032
- 9.3.2 Argentina Nuclear Medicine Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Nuclear Medicine Market Outlook, 2021- 2032
- 10. Middle East and Africa Nuclear Medicine Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Nuclear Medicine Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Nuclear Medicine Market Outlook by Type
- 10.2.2 Middle East and Africa Nuclear Medicine Market Outlook by Application
- 10.3 Middle East and Africa Nuclear Medicine Market Outlook by Country
- 10.3.1 Saudi Arabia Nuclear Medicine Market Outlook, 2021- 2032
- 10.3.2 The UAE Nuclear Medicine Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Nuclear Medicine Market Outlook, 2021- 2032
- 10.3.4 South Africa Nuclear Medicine Market Outlook, 2021- 2032
- 10.3.5 Egypt Nuclear Medicine Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Nuclear Medicine Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Bayer AG
- Bracco Imaging S.p.A.
- Cardinal Health Inc
- Curium Pharma
- Eckert & Ziegler Group
- Eczacibasi-Monrol Nuclear Products
- GE Healthcare
- Isotope JSC
- Jubilant DraxImage Inc
- Lantheus Holdings Inc
- Nordion Inc
- NorthStar Medical Radioisotopes LLC
- NTP Radioisotopes SOC Ltd
- PharmaLogic Holdings Corp
- Siemens Healthineers AG
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
